Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2012
08/16/2012WO2012047679A8 Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria
08/16/2012WO2012040184A3 Novel low molecular weight cationic lipids for oligonucleotide delivery
08/16/2012WO2011126808A9 Pharmacologically induced transgene ablation system
08/16/2012US20120208870 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/16/2012US20120208869 Endometriosis-Related Markers and Uses Thereof
08/16/2012US20120208866 Intact minicells as vectors for dna transfer and gene therapy invitro and invivo
08/16/2012US20120208862 Rip140 regulation of glucose transport
08/16/2012US20120208860 Compositions and methods for inhibiting expression of factor vii gene
08/16/2012US20120208274 Adipose-derived stem cells and lattices
08/16/2012US20120207783 Hiv vaccine formulations
08/16/2012US20120207782 Hiv dna vaccine regulated by a caev-derived promoter
08/16/2012US20120207755 Cancer
08/16/2012US20120207721 Sorcs1 for the treatment of obesity
08/16/2012US20120207716 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells
08/16/2012US20120207711 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
08/16/2012CA2841404A1 Treatment of angiogenesis disorders
08/16/2012CA2826171A1 Neural transfection reagents
08/15/2012EP2486929A1 Therapeutic agent for tumor
08/15/2012EP2486136A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
08/15/2012EP2485770A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery
08/15/2012EP2171448B1 Methods for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
08/15/2012EP1534312B1 Staphylococcal superantigens for combination treatment of lung tumors
08/15/2012EP1446479B1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
08/15/2012EP1420716B1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
08/15/2012EP0833934B2 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/15/2012CN1882693B Polyethyleneglycol-modified lipid compounds and uses thereof
08/15/2012CN102639151A Treatment of hemoglobin (HBF/HBG) related diseases inhibition of natural antisense transcript to HBF/HBG
08/15/2012CN102634531A Medicine T-VISA-PEA15 capable of effectively and specifically killing breast cancer cells
08/15/2012CN102633883A Fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded sequence and application of fusion protein
08/15/2012CN102631687A Multifunctional magnetic nano-carrier for targeted delivery of microRNA, preparation method and application thereof
08/15/2012CN102631686A Porous calcium phosphate nano-particle-antisense oligodeoxyncleotide composite as well as preparation method and application thereof
08/15/2012CN102631671A Therapeutic vaccine for improving vaccine induced cytotoxicity T cellular reaction
08/15/2012CN102199612B Nucleotide sequence used in preparation of Mycobacterium smegmatis vaccine and application thereof
08/15/2012CN101928696B Preparation and application of prostate cancer targeting adenovirus
08/15/2012CN101864434B Sheep aphthovirus Asial type multi-epitope recombinant vaccine and preparation method thereof
08/15/2012CN101676391B A system capable of stably expressing cell cycle factor FoxM1 and its medical use
08/15/2012CN101348512B Antineoplastic ad virus preparation
08/14/2012US8242257 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
08/14/2012US8242256 siRNA useful to supress expression of EIF-5A1
08/14/2012US8242245 Fetal polypeptides from human liver
08/14/2012US8242095 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
08/14/2012US8242093 Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
08/14/2012US8242092 Protein tyrosine phosphatase inhibitors
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242090 Vascular therapeutics
08/14/2012US8242089 Sphingolipids polyalkylamine conjugates for use in transfection
08/14/2012US8242088 Carrier vectors through an epithelium with tight junctions
08/14/2012US8242086 Methods and compositions for treating disorders caused by a deficiency in a gene product of a CLN gene
08/14/2012US8242081 Cell penetrating peptides for intracellular delivery of molecules
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/14/2012US8241639 Extracellular domains of Epstein Barr Virus (EBV) tumor-associated latent membrane proteins
08/14/2012US8241637 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8241623 Protease sensitivity expression system
08/14/2012US8241622 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2457485C Combination motif immune stimulatory oligonucleotides with improved activity
08/14/2012CA2429954C Method for altering cell fate
08/14/2012CA2404679C Adenine binding g-protein coupled receptors
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/14/2012CA2283476C Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
08/09/2012WO2012106702A2 Treatment of leukemia
08/09/2012WO2012106465A2 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions
08/09/2012WO2012106404A2 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
08/09/2012WO2012106377A2 Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
08/09/2012WO2012105984A1 Materials, monitoring, and controlling tissue growth using magnetic nanoparticles
08/09/2012WO2012105931A2 Sin nombre virus full-length m segment-based dna vaccine
08/09/2012WO2012105813A2 Use of icam-1 for prevention or treatment of neurological diseases
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012104386A1 Antagonists of grasp55 for use as a medicament
08/09/2012WO2012074277A3 Novel hybrid promoter and recombinant vector comprising the same
08/09/2012WO2012058627A3 Pre-targeted nanoparticle system and method for labeling biological particles
08/09/2012WO2012054747A3 Methods and compositions for treating tumors using myeloid derived suppressor cells
08/09/2012WO2012018881A3 Methods and compositions for the regulation of rna
08/09/2012US20120204273 Compositions relating to a phosphoprotein and methods of use
08/09/2012US20120203052 Therapeutic regimen for treating cancer
08/09/2012US20120202983 Conjugates and Compositions for Cellular Delivery
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201843 Cyp1b1 nucleic acids and methods of use
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/09/2012US20120201793 Dermal micro-organs, methods and apparatuses for producing and using the same
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201788 Methods and compositions for cell therapy
08/09/2012CA2826199A1 Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
08/09/2012CA2825641A1 Use of icam-1 for prevention or treatment of neurological diseases
08/08/2012EP2484770A1 Complexes of RNA and cationic peptides for transfection and for immunostimulation
08/08/2012EP2484687A2 Methods and compositions for seamless cloning of nucleic acid molecules
08/08/2012EP2483395A1 A nuclear receptor and mutant thereof and the use of the same in the reprogramming of cells
08/08/2012EP2483301A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
08/08/2012EP2482842A1 Cancer therapy
08/08/2012EP2118318B1 Gnaq mutations in melanoma
08/08/2012EP1635763B1 Method of treating neurodegenerative disease
08/08/2012EP1631670B1 Conserved hbv and hcv sequences useful for gene silencing
08/08/2012EP1478750B1 Gene expression by positive feedback activation of a cell type-specific promoter
08/08/2012EP1383536B1 Use of herpesviruses to inhibit ccr5-tropic hiv-1 infection and replication
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 870